全胚冷冻策略中取卵至胚胎移植时间不影响活产率:一项回顾性队列研究
该回顾性队列研究纳入2012年1月至2014年12月间512个全胚冷冻周期,比较取卵后第一个月经周期内(周期1,n=263)与之后(周期≥2,n=249)进行冻胚移植的生殖结局。未校正混杂因素时周期1活产率显著高于周期≥2(37.6% vs 27.3%,P=0.01),但多因素分析未发现移植时机对活产率有影响(OR 0.73,95%CI 0.49-1.08)。作者认为临床医生可能无需等待超过一个月经周期再进行冻胚移植。
要点
- 多因素分析未发现取卵至冻胚移植时间对活产率有显著影响(OR 0.73,95%CI 0.49-1.08)。
- 未校正时周期1活产率显著高于周期≥2(37.6% vs 27.3%,P=0.01)。
- 作者认为临床医生可能无需等待超过一个月经周期再进行冻胚移植。
核心结论
- 本研究未检测到取卵后第一个月经周期内与之后进行冻胚移植的活产率存在统计学显著差异,但不能排除临床相关差异,需要进一步更大规模的研究。
- 作者认为临床医生可能无需等待超过一个月经周期再进行冻胚移植,从而减少不必要的延迟而不影响生殖结局。
研究设计与样本
- 回顾性队列研究,纳入2012年1月至2014年12月间512个全胚冷冻周期。
- 控制性卵巢刺激采用GnRH拮抗剂方案(n=397)或长效GnRH激动剂方案(n=115)。
- 排卵触发采用GnRH激动剂(n=258)或hCG(n=254)。
- 内膜准备采用人工周期,口服雌激素(n=238)或经皮雌激素(n=274)。
- 比较取卵后第一个月经周期内(周期1,n=263)与之后(周期≥2,n=249)进行冻胚移植的生殖结局。
主要发现
- 未校正混杂因素时,周期1冻胚移植的活产率显著高于周期≥2(37.6% vs 27.3%,P=0.01)。
- 生化妊娠率(49.8% vs 43.8%,P=0.17)、临床妊娠率(44.1% vs 36.1%,P=0.07)和流产率(11.8% vs 16.1%,P=0.16)在两组间无显著差异。
- 多因素分析未发现选择性冻胚移植时机对活产率有影响(OR 0.73,95%CI 0.49-1.08)。
- 校正取卵数、排卵触发药物(hCG vs GnRH激动剂)和冷冻保存原因后,移植时机的影响仍不显著。
- 显著影响活产率的因素包括:母亲年龄35-40岁 vs 小于35岁(OR 0.63,95%CI 0.4-0.95)、大于40岁 vs 小于35岁(OR 0.34,95%CI 0.2-0.7)、移植胚胎发育天数第+4天 vs 第+3天(OR 1.7,95%CI 1.1-2.8)、移植胚胎数(OR 2.2,95%CI 1.4-3.3)以及内膜准备所用雌激素经皮 vs 口服(OR 0.62,95%CI 0.4-0.9)。
临床怎么用
- 作者认为临床医生可能无需等待超过一个月经周期再进行冻胚移植,从而减少不必要的延迟而不影响生殖结局。
局限性
- 本研究的主要局限性是其回顾性性质。
- 尽管统计分析了已知和可疑的混杂因素,但不能排除残余混杂因素的可能性。
- 本研究未检测到统计学显著差异,但不能排除临床相关差异,需要进一步更大规模的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does the time from ovum pick-up (OPU) to frozen embryo transfer (FET) affect reproductive outcomes in a freeze-all strategy? SUMMARY ANSWER: Our study did not detect statistically significant differences between first and subsequent cycles, clinically relevant differences are not ruled out and further and larger studies are required. WHAT IS KNOWN ALREADY: Following controlled ovarian hyperstimulation (COH) delaying FET until the endometrium has returned to an optimal pre-stimulation state may have a significant emotional impact on patients, which adds to the stress and anxiety accompanying a standard IVF cycle. Currently there is no agreement on the best time to perform a FET after a freeze-all cycle in order to maximize reproductive outcomes for the patient. STUDY DESIGN, SIZE, DURATION: Retrospective cohort study of 512 freeze-all cycles, performed between January 2012 and December 2014. COH was performed by either a GnRH antagonist (n = 397) or a long GnRH agonist protocol (n = 115). Ovulation was triggered using either a GnRH agonist (n = 258) or hCG (n = 254). Endometrial preparation was performed in an artificial cycle by either oral (n = 238) or transdermal (n = 274) oestrogen. Differences were considered significant if P < 0.05. PARTICIPANTS/MATERIALS, SETTING, METHODS: Reproductive outcomes between FETs which took place either within the first menstrual cycle following OPU (Cycle 1; n = 263) or afterwards (Cycle ≥2; n = 249) were compared. Student's t-test for independent samples, Mann-Whitney U-test and Chi-square analysis were used where appropriate. A multivariable logistic regression analysis was performed adjusting for maternal age, drug used for ovulation trigger, number of retrieved oocytes, number of embryos obtained, day of embryonic development at transfer, number of embryos transferred and type of endometrial preparation. Differences were considered significant if P < 0.05. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth rate (LBR) was significantly higher in FET performed during Cycle 1 vs Cycle ≥2 (37.6% vs 27.3%, respectively; P = 0.01) before adjusting for confounding factors. We found no difference for biochemical pregnancy (49.8% vs 43.8%; P = 0.17), clinical pregnancy (44.1% vs 36.1%; P = 0.07) or pregnancy loss (11.8% vs 16.1%; P = 0.16). A multivariable analysis found no impact of timing of elective FET on LBR (odds ratio, OR 0.73; 95% CI 0.49-1.08). The impact remained not significant after adjusting for number of retrieved oocytes, drug used for ovulation trigger (hCG vs GnRH agonist) and reason for cryopreservation. The factors that significantly affected LBR were: maternal age in both age categories (women between 35 and 40 years vs women below 35 years, OR 0.63, 95% CI 0.4-0.95; and women over 40 years vs women below 35 years, OR 0.34, 95% CI 0.2-0.7), day of embryonic development at transfer (day +4 vs +3; OR 1.7, 95% CI 1.1-2.8) and number of transferred embryos (OR 2.2, 95% CI 1.4-3.3) and oestrogen used for endometrial preparation (transdermal vs oral; OR 0.62, 95% CI 0.4-0.9). LIMITATIONS REASONS FOR CAUTION: The main limitation of our study is its retrospective nature. Although we adjusted our statistical analysis for a number of known and suspected confounders, we cannot exclude the possibility of residual confounding factors. WIDER IMPLICATIONS OF THE FINDINGS: According to our results, clinicians might not need to wait more than one menstrual cycle before performing FET. This allows us to reduce unnecessary delays in FET, without compromising reproductive outcomes. STUDY FUNDING/COMPETING INTERESTS: No funding was sought for this study. Authors declare no competing interests. TRIAL REGISTRATION NUMBER: NA.
引用
- Lattes K, Checa MA, Vassena R, et al. There is no evidence that the time from egg retrieval to embryo transfer affects live birth rates in a freeze-all strategy. Hum Reprod. 2016. PMID: 27986819. doi:10.1093/humrep/dew306
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。